Skip to main content
Erschienen in: Journal of Gastrointestinal Cancer 2/2018

12.11.2016 | Case Report

Long-Term Survival with Chemoradiation Alone in Locally Advanced Unresectable Gallbladder Cancer: First Case Report of a New Paradigm

verfasst von: Sushma Agrawal

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Excerpt

Gallbladder cancer (GBC) is endemic in North India in the Indo-Gangetic belt and usually presents as unresectable or metastatic disease [1]. Palliative chemotherapy is the only treatment which yields a median survival of 9 months [2]. Unresectable GBCs are those which are involving the portal vein, hepatic artery, or contiguous organs and those with distant nodal disease or metastases. Attempt at neoadjuvant strategies in non-metastatic locally advanced gallbladder cancer shows resectability rates ranging from 15–40% [3, 4]. Survival beyond 25 months has not been reported with this strategy. We report the first case with 8-year-survival after chemoradiation in a woman with locally advanced gallbladder cancer. …
Literatur
1.
Zurück zum Zitat Three-Year Report of Population Based Cancer Registries 2009–2011, National Cancer Registry Programme (Indian Council of Medical Research), 2013. http://ncrpindia.org Three-Year Report of Population Based Cancer Registries 2009–2011, National Cancer Registry Programme (Indian Council of Medical Research), 2013. http://​ncrpindia.​org
2.
Zurück zum Zitat Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273–81.CrossRefPubMed Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273–81.CrossRefPubMed
3.
Zurück zum Zitat Sirohi B, Mitra A, Jagannath P, et al. Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer. Future Oncol. 2015;11(10):1501–9.CrossRefPubMed Sirohi B, Mitra A, Jagannath P, et al. Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer. Future Oncol. 2015;11(10):1501–9.CrossRefPubMed
4.
Zurück zum Zitat Agrawal S, Mohan L, Mourya C, et al. Radiologic downstaging with neoadjuvant therapy in locally advanced gallbladder cancer. Asian Pac J Cancer Prev. 2016;17(4):2137–40.CrossRefPubMed Agrawal S, Mohan L, Mourya C, et al. Radiologic downstaging with neoadjuvant therapy in locally advanced gallbladder cancer. Asian Pac J Cancer Prev. 2016;17(4):2137–40.CrossRefPubMed
5.
Zurück zum Zitat Beets GL, Figueiredo NL, Habr-Gama A, van de Velde CJ. A new paradigm for rectal cancer: organ preservation: introducing the International Watch & Wait Database (IWWD). Eur J Surg Oncol. 2015;Dec;41(12):1562–4.CrossRef Beets GL, Figueiredo NL, Habr-Gama A, van de Velde CJ. A new paradigm for rectal cancer: organ preservation: introducing the International Watch & Wait Database (IWWD). Eur J Surg Oncol. 2015;Dec;41(12):1562–4.CrossRef
6.
Zurück zum Zitat Engineer R, Goel M, Chopra S, et al. Neoadjuvant chemoradiation followed by surgery for locally advanced gallbladder cancers: a new paradigm. Ann Surg Oncol. 2016;23(9):3009–15.CrossRefPubMed Engineer R, Goel M, Chopra S, et al. Neoadjuvant chemoradiation followed by surgery for locally advanced gallbladder cancers: a new paradigm. Ann Surg Oncol. 2016;23(9):3009–15.CrossRefPubMed
7.
Zurück zum Zitat Kato A, Shimizu H, Ohtsuka M, et al. Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single-center study. Ann Surgical Oncol. 2013;20:318–24.CrossRef Kato A, Shimizu H, Ohtsuka M, et al. Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single-center study. Ann Surgical Oncol. 2013;20:318–24.CrossRef
Metadaten
Titel
Long-Term Survival with Chemoradiation Alone in Locally Advanced Unresectable Gallbladder Cancer: First Case Report of a New Paradigm
verfasst von
Sushma Agrawal
Publikationsdatum
12.11.2016
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Cancer / Ausgabe 2/2018
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-016-9893-6

Weitere Artikel der Ausgabe 2/2018

Journal of Gastrointestinal Cancer 2/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.